24 results for: Biotechnology and Medical Research
Photograph
Dace Krasts working in lab at Immunex, Seattle, December 13, 1990
Scientists Steven Gillis and Christopher Henney, along with businessman Stephen Duzan, founded Immunex in July 1981. They envisioned the company's mission as developing, producing, and licensing diagnostic and therapeutic immunological products. Its successful drugs included LEUKINE (sargramostin) for patients undergoing bone marrow transplants, NOVANTRONE for multiple sclerosis, and ENBREL (etanercept), an anti-inflammatory used to treat arthritis. By 2001 Immunex was…
ID Number:2000.107.095.22.06
Date:1990
Photograph
Immunex manufacturing and development center, Bothell, October 15, 1992
Scientists Steven Gillis and Christopher Henney, along with businessman Stephen Duzan, founded Immunex in July 1981. They envisioned the company's mission as developing, producing, and licensing diagnostic and therapeutic immunological products. Its successful drugs included LEUKINE (sargramostin) for patients undergoing bone marrow transplants, NOVANTRONE for multiple sclerosis, and ENBREL (etanercept), an anti-inflammatory used to treat arthritis. By 2001 Immunex was…
ID Number:2000.107.095.22.07
Date:1992
Photograph
Product technician inspecting package at IMRE Corporation lab, Seattle, March 1, 1993
IMRE Corporation, one of Seattle's pioneering biotechnology companies, was founded in 1981, and went public in 1983. Their major product, the Prosorba Column, invented by CEO Frank R. Jones, filters immune complexes from blood plasma to treat some immune diseases, and was the first device of its kind to receive FDA approval, granted in 1987. The company rebranded as Cypress…
ID Number:2000.107.095.22.08
Date:1993
Photograph
Rikuko Tanaka being examined by Dr. Michio Yamakido, Seattle, May 23, 1981
In this image, Rikuko Tanaka is examined by Dr. Michio Yamakido at the Public Health Service Hospital in Seattle. Tanaka was a survivor of the US nuclear bombing of Hiroshima in 1945. This exam was part of a study conducted by the Japanese government which aimed to keep track of the health of atom bomb survivors living in the US…
ID Number:2000.107.098.19.07
Date:1981
Photograph
Fred Hutchinson Cancer Research Center under construction, Seattle, August 15, 1991
Seattle's world-renowned research facility, the Fred Hutchinson Cancer Research Center, was named for baseball great and hometown hero Frederick Charles "Hutch" Hutchinson (1919-1964). Begun as the Pacific Northwest Research Foundation in 1956 by Dr. William B. "Bill" Hutchinson (1909–1997), Hutch's brother, the Foundation was dedicated to the study of heart surgery, cancer, and diseases of the endocrine system. The center…
ID Number:2000.107.175.09.01
Date:1991
Photograph
Joseph P. Balint Jr. holding Prosorba Column device at IMRE Corp., Seattle, March 22, 1993
The biotechnology company IMRE Corp. was formed in Seattle in 1981 as Immune Response Systems, Inc., by a group of scientific investigators from various institutions across the country. IMRE moved to San Diego in 1996 and changed its name to Cypress Bioscience. In the early 1980s, IMRE Corp. invented a device for filtering a person’s blood to strengthen the immune…
ID Number:2000.107.19930322.5.42
Date:1993
Photograph
Construction on new ZymoGenetics headquarters, Seattle, July 27, 1993
ZymoGenetics was established in Seattle in 1981 by University of Washington professors Earl Davie and Benjamin Hall, along with University of British Columbia professor Michael Smith. One of the oldest biotechnology/pharmaceutical companies in the U.S., ZymoGenetics was involved in the development of therapeutic proteins. The company was acquired by Novo Nordisk in 1988, and was spun off as a public…
ID Number:2000.107.19930727.1.31
Date:1993
Photograph
Immunex CEO Ed Fritzky, Seattle, March 13, 1997
Scientists Steven Gillis and Christopher Henney, along with businessman Stephen Duzan, founded Immunex in July 1981. They envisioned the company's mission as developing, producing, and licensing diagnostic and therapeutic immunological products. Its successful drugs included LEUKINE (sargramostin) for patients undergoing bone marrow transplants, NOVANTRONE for multiple sclerosis, and ENBREL (etanercept), an anti-inflammatory used to treat arthritis. By 2001 Immunex was…
ID Number:2000.107.19970313.1.02
Date:1997
Photograph
Rick Murdock, CEO of CellPro Inc., Bothell, April 22, 1997
Rick Murdock founded CellPro Inc. to develop new cancer treatments. The company’s first project was a process to separate, purify, and concentrate stem cells from bone marrow that could then be transferred into patients to treat lymphoma, breast cancer, and multiple myeloma. Unexpectedly, Murdock developed a type of cancer that CellPro’s product could treat. At about the same time, the…
ID Number:2000.107.19970422.13.09
Date:1997
Document
ZymoGenetics annual report, 2001
ZymoGenetics was established in Seattle in 1981 by University of Washington professors Earl Davie and Benjamin Hall, along with University of British Columbia professor Michael Smith. One of the oldest biotechnology/pharmaceutical companies in the U.S., ZymoGenetics was involved in the development of therapeutic proteins. The company was acquired by Novo Nordisk in 1988, and was spun off as a public…
ID Number:2005.26.1
Date:2001